Research ArticleClinical Investigation
Somatostatin Receptor Scintigraphy in Pituitary Adenomas: A Somatostatin Receptor Density Index Can Predict Hormonal and Tumoral Efficacy of Octreotide In Vivo
Michèle Duet, Christiane Ajzenberg, Salah Benelhadj, Elisabeth Lajeunie, Boris Lormeau, Pierre-Jean Guillausseau, Vincens Rohmer, Didier Vilain, Olivier Mundler and André Warnet
Journal of Nuclear Medicine August 1999, 40 (8) 1252-1256;
Michèle Duet
Christiane Ajzenberg
Salah Benelhadj
Elisabeth Lajeunie
Boris Lormeau
Pierre-Jean Guillausseau
Vincens Rohmer
Didier Vilain
Olivier Mundler


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Somatostatin Receptor Scintigraphy in Pituitary Adenomas: A Somatostatin Receptor Density Index Can Predict Hormonal and Tumoral Efficacy of Octreotide In Vivo
Michèle Duet, Christiane Ajzenberg, Salah Benelhadj, Elisabeth Lajeunie, Boris Lormeau, Pierre-Jean Guillausseau, Vincens Rohmer, Didier Vilain, Olivier Mundler, André Warnet
Journal of Nuclear Medicine Aug 1999, 40 (8) 1252-1256;
Somatostatin Receptor Scintigraphy in Pituitary Adenomas: A Somatostatin Receptor Density Index Can Predict Hormonal and Tumoral Efficacy of Octreotide In Vivo
Michèle Duet, Christiane Ajzenberg, Salah Benelhadj, Elisabeth Lajeunie, Boris Lormeau, Pierre-Jean Guillausseau, Vincens Rohmer, Didier Vilain, Olivier Mundler, André Warnet
Journal of Nuclear Medicine Aug 1999, 40 (8) 1252-1256;
Jump to section
Related Articles
- No related articles found.